These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 36338968)
1. Driving down malaria transmission with engineered gene drives. Garrood WT; Cuber P; Willis K; Bernardini F; Page NM; Haghighat-Khah RE Front Genet; 2022; 13():891218. PubMed ID: 36338968 [TBL] [Abstract][Full Text] [Related]
2. Modelling the suppression of a malaria vector using a CRISPR-Cas9 gene drive to reduce female fertility. North AR; Burt A; Godfray HCJ BMC Biol; 2020 Aug; 18(1):98. PubMed ID: 32782000 [TBL] [Abstract][Full Text] [Related]
3. Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito. Garrood WT; Kranjc N; Petri K; Kim DY; Guo JA; Hammond AM; Morianou I; Pattanayak V; Joung JK; Crisanti A; Simoni A Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050017 [TBL] [Abstract][Full Text] [Related]
4. Control of malaria-transmitting mosquitoes using gene drives. Nolan T Philos Trans R Soc Lond B Biol Sci; 2021 Feb; 376(1818):20190803. PubMed ID: 33357060 [TBL] [Abstract][Full Text] [Related]
5. Cas9-mediated maternal effect and derived resistance alleles in a gene-drive strain of the African malaria vector mosquito, Anopheles gambiae. Carballar-Lejarazú R; Tushar T; Pham TB; James AA Genetics; 2022 May; 221(2):. PubMed ID: 35389492 [TBL] [Abstract][Full Text] [Related]
8. Transforming malaria prevention and control: the prospects and challenges of gene drive technology for mosquito management. Tajudeen YA; Oladipo HJ; Oladunjoye IO; Oladipo MK; Shittu HD; Abdulmumeen IF; Afolabi AO; El-Sherbini MS Ann Med; 2023; 55(2):2302504. PubMed ID: 38232762 [No Abstract] [Full Text] [Related]
9. Bioinformatic and literature assessment of toxicity and allergenicity of a CRISPR-Cas9 engineered gene drive to control Anopheles gambiae the mosquito vector of human malaria. Qureshi A; Connolly JB Malar J; 2023 Aug; 22(1):234. PubMed ID: 37580703 [TBL] [Abstract][Full Text] [Related]
10. Engineered Gut Symbiotic Bacterium-Mediated RNAi for Effective Control of Ding J; Cui C; Wang G; Wei G; Bai L; Li Y; Sun P; Dong L; Liu Z; Yun J; Li F; Li K; He L; Wang S Microbiol Spectr; 2023 Aug; 11(4):e0166623. PubMed ID: 37458601 [No Abstract] [Full Text] [Related]
11. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Hammond A; Galizi R; Kyrou K; Simoni A; Siniscalchi C; Katsanos D; Gribble M; Baker D; Marois E; Russell S; Burt A; Windbichler N; Crisanti A; Nolan T Nat Biotechnol; 2016 Jan; 34(1):78-83. PubMed ID: 26641531 [TBL] [Abstract][Full Text] [Related]
12. Dual effector population modification gene-drive strains of the African malaria mosquitoes, Carballar-Lejarazú R; Dong Y; Pham TB; Tushar T; Corder RM; Mondal A; Sánchez C HM; Lee HF; Marshall JM; Dimopoulos G; James AA Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2221118120. PubMed ID: 37428915 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector. Nourani L; Mehrizi AA; Pirahmadi S; Pourhashem Z; Asadollahi E; Jahangiri B Infect Genet Evol; 2023 Apr; 109():105419. PubMed ID: 36842543 [TBL] [Abstract][Full Text] [Related]